Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Expanding Variant-Aware Strategies for Rare Disease Diagnosis
by
Bowles, Bradley Scott
in
Bioinformatics
/ Medicine
/ Pathology
2022
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Expanding Variant-Aware Strategies for Rare Disease Diagnosis
by
Bowles, Bradley Scott
in
Bioinformatics
/ Medicine
/ Pathology
2022
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Expanding Variant-Aware Strategies for Rare Disease Diagnosis
Dissertation
Expanding Variant-Aware Strategies for Rare Disease Diagnosis
2022
Request Book From Autostore
and Choose the Collection Method
Overview
Rare diseases are collectively far more common than their designation might imply, and they represent a significant source of global disease burden, infant mortality, and healthcare costs. Expansive sequencing technologies such as genome sequencing represent some of the most efficient ways to diagnose patients with suspected genetic disease, and the clinical use of sequencing has expanded greatly in recent years. Genome sequencing, one of the most comprehensive sequencing technologies, is estimated to deliver a diagnosis to an impressive 34-48% of sequenced patients. The remaining patients have little recourse for receiving a molecular diagnosis and the subsequent treatment, prognosis, or genetic counseling that diagnosis allows. Limited knowledge of genome function, and limited ability to interpret the effects of genetic changes, represent crucial translational hurdles that prevent clinicians from fully leveraging the power of sequencing technology to diagnose patients. Increasingly, the challenges of rare disease diagnosis are becoming not how to sequence patients and collect genetic information, but how to interpret the wealth of genetic information obtained by sequencing. This thesis document will introduce new methods which span clinical and research approaches to interpret the significance of genetic variants and deliver precise diagnoses to rare disease patients.
Publisher
ProQuest Dissertations & Theses
Subject
ISBN
9798380590662
This website uses cookies to ensure you get the best experience on our website.